MedPath

Evaluation of the Efficacy of Preoperative Ketamine Nebulization on Postoperative Sore Throat Due to Tracheal Intubation for Adult Patients Under General Anesthesia, A Prospective Randomized Controlled Study

Not yet recruiting
Conditions
Post Operative Sore Throat
Interventions
Other: saline nebulization
Drug: Ketamine
Registration Number
NCT05975346
Lead Sponsor
Sohag University
Brief Summary

Sore throat includes specific symptoms such as dysphagia, dysphonia, hoarseness, continuous throat pain, and pharyngeal dryness. Patients rated postoperative sore throat (POST) as the eighth most undesirable outcome in the postoperative period POST has a reported incidence of up to 62% following general anesthesia (GA). The incidence of POST is more common in GA with tracheal intubation than in GA with the supraglottic airway Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist and has been used as a gargle for reducing the incidence and severity of POST due to its anti-nociceptive and anti-inflammatory effects

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria
  1. Age 16-60 years.
  2. Of both sex.
  3. American Society of Anesthesiologists Physical Status (ASA PS) I-II.
  4. Undergoing general anesthesia with endotracheal intubation with surgery duration less than two hours.
Read More
Exclusion Criteria
  • a- History of chronic obstructive History of sore throat or upper respiratory tract infection.

    b- Intraoral and intrapharyngeal surgery. c- airway disease or Asthma. d- Mallampati grade more than II. e- Known allergic to study drug. f- More than one attempt is required for intubation. g- Hypertensive patients. h- Epileptic patients. i- cerebral palsy or any neurological disorders. j- Psychiatry patients. k- Cardiac patients. l- Perioperative use of anti-inflammatory drugs (Non-steroidal anti-inflammatory drug or steroids).

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
(S) Saline groupsaline nebulization40 patients will receive saline nebulization (5ml).
(K) Ketamine groupKetamine40 patients will receive ketamine 50mg (1.0 ml with 4.0 ml of the saline) nebulization
Primary Outcome Measures
NameTimeMethod
the incidence and severity of POSTat immediate recovery (0 h), 2, 4, 6, 8, 12 and 24 h post-operatively.

the study is to measure the incidence and severity of POST at immediate recovery (0 h), 2, 4, 6, 8, 12 and 24 h post-operatively. in adult patients undergoing surgery of a duration less than 2h.

Secondary Outcome Measures
NameTimeMethod
evaluation of side effects including nausea, vomiting, cough, and dry mouth in both groups.at immediate recovery (0 h), 2, 4, 6, 8, 12 and 24 h post-operatively.

evaluation of side effects including nausea, vomiting, cough, and dry mouth in both groups.

© Copyright 2025. All Rights Reserved by MedPath